You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-L3MBTL2 antibody (ab80489)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-L3MBTL2 antibody
See all L3MBTL2 products (5) ...

Description

Rabbit polyclonal to L3MBTL2

Tested applications

WB, ELISAmore details

Cross reactivity

Reacts with

Human

Predicted to work with

Mouse, Rat, Cow, Dog

Immunogen

Synthetic peptide corresponding to a region of human L3MBTL2 (NP_001003689)

Positive control

HeLa cell lysate.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: 2% Sucrose, PBS

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Purification notes

ab80489 is purified by a peptide affinity chromatography method.

Clonality

Polyclonal

Isotype

IgG

  • Western blot - L3MBTL2 antibody (ab80489)Western blot - L3MBTL2 antibody (ab80489) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab80489 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ELISA: Use at an assay dependent dilution.
ELISA titre using peptide based assay: 1/312500.
WB: Use at a concentration of 1.0 µg/ml. Predicted molecular weight: 69 kDa (for NP_001003689).

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Putative Polycomb group (PcG) protein. PcG proteins maintain the transcriptionally repressive state of genes, probably via a modification of chromatin, rendering it heritably changed in its expressibility. Its association with a chromatin-remodeling complex suggests that it may contribute to prevent expression of genes that trigger the cell into mitosis. Binds to monomethylated and dimethylated 'Lys-20' on histone H4. Binds histone H3 peptides that are monomethylated or dimethylated on 'Lys-4', 'Lys-9' or 'Lys-27'.

Sequence similarities

Contains 1 FCS-type zinc finger.
Contains 4 MBT repeats.

Cellular localization

Nucleus.

Target information above from: UniProt accessionQ969R5 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • 3bt like 2 protein antibody
  • 3bt like protein antibody
  • DKFZP761I141 antibody
  • H-l(3)mbt-like protein 2 antibody
  • H-l(3)mbt-like protein antibody
  • Hl antibody
  • Hl(3)mbt like protein antibody
  • Hl(3)mbtl antibody
  • L antibody
  • l(3)mbt like 2 (Drosophila) antibody
  • l(3)mbt like 2 antibody
  • L(3)mbt-like 2 protein antibody
  • L(3)mbt-like protein 2 antibody
  • L3MBTL2 antibody
  • Lethal antibody
  • Lethal(3)malignant brain tumor-like 2 protein antibody
  • Lethal(3)malignant brain tumor-like protein 2 antibody
  • LMBL2_HUMAN antibody
see all

Anti-L3MBTL2 antibody images:

  Western blot - L3MBTL2 antibody (ab80489)

Western blot - L3MBTL2 antibody (ab80489)

Anti-L3MBTL2 antibody (ab80489) at 1 µg/ml + HeLa cell lysate at 10 µg

Secondary
HRP conjugated anti-Rabbit IgG at 1/50000 dilution

Predicted band size : 69 kDa
Observed band size : 69 kDa
Additional bands at : 27 kDa,40 kDa. We are unsure as to the identity of these extra bands.

References for Anti-L3MBTL2 antibody (ab80489)

ab80489 has not yet been referenced specifically in any publications.

Publishing research using ab80489? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"